HSA Product

REWISCA HARD CAPSULES 25MG

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

REWISCA HARD CAPSULES 25MG

Dosage Form

CAPSULE

Regulatory Information

Approval Number

SIN15657P

Approval Date

April 2, 2019

Forensic Classification

Prescription Only

Drug Type

Therapeutic

Route of Administration

ORAL

Record Created

August 10, 2023

Last Updated

June 3, 2025

Company Information

ManufacturerKRKA, d.d., Novo mesto

Registrant

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

Strength: 25.00mg

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy